NEXGEL, INC. Accounts Receivable, Allowance for Credit Loss
NEXGEL, INC. (NXGL) had Accounts Receivable, Allowance for Credit Loss of $13.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2026-08-17
- 2026-06-30: Accounts Receivable, Allowance for Credit Loss $13.00K.
- 2026-03-31: Accounts Receivable, Allowance for Credit Loss $9.00K.
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss $9.00K.
- 2025-09-30: Accounts Receivable, Allowance for Credit Loss $7.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss |
|---|---|
| 2026-06-30 | $13.00K 10-Q · filed 2026-08-17 |
| 2026-03-31 | $9.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $9.00K 10-Q · filed 2026-08-17 |
| 2025-09-30 | $7.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $8.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $6.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $5.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $19.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $18.00K 10-Q · filed 2024-08-19 |
| 2024-03-31 | $12.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $11.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $17.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $17.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $19.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $9.00K 10-K · filed 2024-04-10 |
| 2022-09-30 | $10.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $6.00K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $2.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $4.00K 10-K · filed 2023-03-28 |
| 2021-09-30 | $4.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $4.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $3.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $1.00K 10-K · filed 2022-03-21 |
| 2019-12-31 | $2.00K 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |